AIXN
AiXin Life International, Inc.
Price Chart
Latest Quote
$0.17
Current Price| Previous Close | $0.17 |
| Open | $0.17 |
| Day High | $0.17 |
| Day Low | $0.17 |
| Volume | 700 |
Stock Information
| Shares Outstanding | 25.00M |
| Total Debt | $1.31M |
| Cash Equivalents | $109K |
| Revenue | $1.87M |
| Net Income | $-2.86M |
| Sector | Consumer Defensive |
| Industry | Food Distribution |
| Market Cap | $4.19M |
| EPS (TTM) | $-0.11 |
| Exchange | OQB |
đ Custom Metrics & Score
Score: 14/42| Debt to Equity | -0.31 |
| Debt to Earnings | 2.17 |
| Current Ratio | 0.19 |
| Quick Ratio | 0.11 |
| Avg Revenue Growth | 6.18% |
| Profit Margin | -72.39% |
| Return on Equity | 64.64% |
| Avg FCF Growth | 766.81% |
| FCF Yield | -44.74% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.17 | 0 |
| 2026-01-30 | $0.17 | 0 |
| 2026-01-29 | $0.17 | 0 |
| 2026-01-28 | $0.17 | 0 |
| 2026-01-27 | $0.17 | 0 |
| 2026-01-26 | $0.17 | 0 |
| 2026-01-23 | $0.17 | 0 |
| 2026-01-22 | $0.17 | 3,000 |
| 2026-01-21 | $0.17 | 0 |
| 2026-01-20 | $0.17 | 0 |
| 2026-01-16 | $0.17 | 0 |
| 2026-01-15 | $0.17 | 0 |
| 2026-01-14 | $0.17 | 0 |
| 2026-01-13 | $0.17 | 0 |
| 2026-01-12 | $0.17 | 0 |
| 2026-01-09 | $0.17 | 0 |
| 2026-01-08 | $0.17 | 0 |
| 2026-01-07 | $0.17 | 0 |
| 2026-01-06 | $0.17 | 0 |
| 2026-01-05 | $0.17 | 0 |
About AiXin Life International, Inc.
AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat's milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.
đ° Latest News
No news articles available at the moment. Check back later for updates on AIXN.
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $3,214,963 | $3,425,015 | $2,843,108 | $535,485 |
| Cost Of Revenue | $3,214,963 | $3,425,015 | $2,843,108 | $535,485 |
| Total Revenue | $3,824,301 | $4,089,799 | $2,708,560 | $3,066,233 |
| Operating Revenue | $3,824,301 | $4,089,799 | $2,590,027 | $3,003,276 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Expenses | $6,412,492 | $6,588,606 | $5,278,019 | $3,093,171 |
| Other Income Expense | $-103,009 | $426,794 | $-3,803,565 | $29,910 |
| Other Non Operating Income Expenses | $-103,009 | $426,794 | $20,205 | $29,910 |
| Net Non Operating Interest Income Expense | $-76,613 | $838 | $4,876 | $4,113 |
| Total Other Finance Cost | $76,613 | $-838 | - | - |
| Operating Expense | $3,197,529 | $3,163,591 | $2,434,911 | $2,557,686 |
| Selling And Marketing Expense | $791,104 | $888,745 | $787,637 | $470,798 |
| General And Administrative Expense | $2,406,425 | $2,274,846 | $1,766,548 | $1,405,370 |
| Other Operating Expenses | - | - | $1,739,948 | $744,594 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-2,768,341 | $-2,090,694 | $-6,369,245 | $-267,236 |
| Net Interest Income | $-76,613 | $838 | $4,876 | $4,113 |
| Normalized Income | $-2,768,341 | $-2,090,694 | $-2,545,475 | $-267,236 |
| Net Income From Continuing And Discontinued Operation | $-2,768,341 | $-2,090,694 | $-6,369,245 | $-267,236 |
| Total Operating Income As Reported | $-2,588,191 | $-2,498,807 | $-2,569,459 | $-26,938 |
| Net Income Common Stockholders | $-2,768,341 | $-2,090,694 | $-6,369,245 | $-267,236 |
| Net Income | $-2,768,341 | $-2,090,694 | $-6,369,245 | $-267,236 |
| Net Income Including Noncontrolling Interests | $-2,768,341 | $-2,090,694 | $-6,369,245 | $-267,236 |
| Net Income Continuous Operations | $-2,768,341 | $-2,090,694 | $-6,369,245 | $-267,236 |
| Pretax Income | $-2,767,813 | $-2,071,175 | $-6,368,148 | $7,085 |
| Operating Income | $-2,588,191 | $-2,498,807 | $-2,569,459 | $-26,938 |
| Gross Profit | $609,338 | $664,784 | $-134,548 | $2,530,748 |
| Interest Income | - | $838 | $4,876 | $4,113 |
| Special Income Charges | - | $0 | $-3,823,770 | $0 |
| Interest Income Non Operating | - | $838 | $4,876 | $4,113 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-0.11 | $-0.08 | $-0.26 | $-0.01 |
| Basic EPS | $-0.11 | $-0.08 | $-0.26 | $-0.01 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,266,909 | $-2,088,117 | $1,439,876 | $69,168 |
| Reconciled Depreciation | $321,282 | $410,690 | $185,565 | $96,106 |
| EBITDA (Bullshit earnings) | $-2,266,909 | $-2,088,117 | $-2,383,894 | $69,168 |
| EBIT | $-2,588,191 | $-2,498,807 | $-2,569,459 | $-26,938 |
| Diluted Average Shares | $24,999,834 | $24,999,834 | $24,999,842 | $24,999,842 |
| Basic Average Shares | $24,999,834 | $24,999,834 | $24,999,842 | $24,999,842 |
| Diluted NI Availto Com Stockholders | $-2,768,341 | $-2,090,694 | $-6,369,245 | $-267,236 |
| Tax Provision | $528 | $19,519 | $1,097 | $274,321 |
| Selling General And Administration | $3,197,529 | $3,163,591 | $2,554,185 | $1,876,168 |
| Other Gand A | $2,105,298 | $1,903,306 | $1,395,008 | $1,033,830 |
| Salaries And Wages | $301,127 | $371,540 | $371,540 | $371,540 |
| Total Unusual Items | - | $0 | $-3,823,770 | $0 |
| Total Unusual Items Excluding Goodwill | - | $0 | $-3,823,770 | $0 |
| Impairment Of Capital Assets | - | $0 | $3,823,770 | $0 |
| Provision For Doubtful Accounts | - | $-43,988 | $-119,274 | $-63,076 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-4,286,917 | $-1,915,498 | $-467,457 | $6,067,551 |
| Total Assets | $4,406,360 | $4,842,358 | $5,050,884 | $11,660,346 |
| Total Non Current Assets | $2,952,652 | $3,344,914 | $3,074,895 | $2,454,811 |
| Non Current Prepaid Assets | $4,051 | $84,508 | $86,992 | $94,153 |
| Goodwill And Other Intangible Assets | $4,514 | $3,917 | $1,269 | $1,940 |
| Other Intangible Assets | $4,514 | $3,917 | $1,269 | $1,940 |
| Current Assets | $1,453,708 | $1,497,444 | $1,975,989 | $9,205,535 |
| Restricted Cash | $0 | $23,208 | $109,772 | $44,211 |
| Prepaid Assets | $92,627 | $289,919 | $193,559 | $281,623 |
| Inventory | $503,990 | $441,098 | $499,252 | $233,454 |
| Receivables | $794,781 | $299,461 | $663,278 | $89,605 |
| Other Receivables | $72,532 | $33,475 | $17,595 | $24,627 |
| Accounts Receivable | $668,465 | $253,586 | $562,581 | $45,923 |
| Allowance For Doubtful Accounts Receivable | $-52,669 | $-80,640 | $-272,550 | $-213,787 |
| Gross Accounts Receivable | $721,134 | $334,226 | $835,131 | $259,710 |
| Cash Cash Equivalents And Short Term Investments | $62,310 | $443,758 | $510,128 | $8,556,642 |
| Cash And Cash Equivalents | $62,310 | $443,758 | $510,128 | $8,556,642 |
| Non Current Deferred Assets | - | $0 | $15,556 | $18,795 |
| Non Current Deferred Taxes Assets | - | $0 | $15,556 | $18,795 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $1,322,174 | $1,738,516 | $1,165,300 | $2,081,093 |
| Long Term Debt And Capital Lease Obligation | $1,213,892 | $789,489 | $194,725 | $1,138,710 |
| Current Debt And Capital Lease Obligation | $108,282 | $949,027 | $970,575 | $942,383 |
| Current Debt | - | $84,508 | $86,992 | $94,153 |
| Other Current Borrowings | - | $84,508 | $86,992 | $94,153 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $8,688,763 | $6,753,939 | $5,517,072 | $5,590,855 |
| Total Non Current Liabilities Net Minority Interest | $1,213,892 | $789,489 | $194,725 | $1,138,710 |
| Current Liabilities | $7,474,871 | $5,964,450 | $5,322,347 | $4,452,145 |
| Current Deferred Liabilities | $861,367 | $1,095,991 | $1,089,873 | $171,408 |
| Payables And Accrued Expenses | $6,343,880 | $3,687,449 | $2,991,550 | $3,010,619 |
| Payables | $5,255,129 | $3,117,190 | $2,406,271 | $2,739,357 |
| Other Payable | $1,329,089 | $1,360,824 | $1,500,862 | $153,403 |
| Total Tax Payable | $103,945 | $49,249 | $104,100 | $232,637 |
| Income Tax Payable | $29,216 | $29,998 | $30,919 | $109,396 |
| Accounts Payable | $864,623 | $480,232 | $564,427 | $406,163 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $-4,282,403 | $-1,911,581 | $-466,188 | $6,069,491 |
| Total Equity Gross Minority Interest | $-4,282,403 | $-1,911,581 | $-466,188 | $6,069,491 |
| Stockholders Equity | $-4,282,403 | $-1,911,581 | $-466,188 | $6,069,491 |
| Gains Losses Not Affecting Retained Earnings | $429,530 | $333,138 | $324,837 | $862,811 |
| Other Equity Adjustments | $429,530 | $333,138 | $324,837 | $862,811 |
| Retained Earnings | $-19,988,733 | $-17,220,392 | $-15,249,858 | $-8,880,613 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $24,999,834 | $24,999,834 | $24,999,842 | $24,999,945 |
| Share Issued | $24,999,834 | $24,999,834 | $24,999,842 | $24,999,945 |
| Tangible Book Value | $-4,286,917 | $-1,915,498 | $-467,457 | $6,067,551 |
| Invested Capital | $-4,282,403 | $-1,827,073 | $-379,196 | $6,163,644 |
| Working Capital | $-6,021,163 | $-4,467,006 | $-3,346,358 | $4,753,390 |
| Capital Lease Obligations | $1,322,174 | $1,654,008 | $1,078,308 | $1,986,940 |
| Total Capitalization | $-4,282,403 | $-1,911,581 | $-466,188 | $6,069,491 |
| Additional Paid In Capital | $15,276,550 | $14,975,423 | $14,458,583 | $14,087,043 |
| Capital Stock | $250 | $250 | $250 | $250 |
| Common Stock | $250 | $250 | $250 | $250 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,213,892 | $789,489 | $194,725 | $1,138,710 |
| Current Deferred Revenue | $861,367 | $1,095,991 | $1,089,873 | $171,408 |
| Current Capital Lease Obligation | $108,282 | $864,519 | $883,583 | $848,230 |
| Pensionand Other Post Retirement Benefit Plans Current | $161,342 | $231,983 | $270,349 | $327,735 |
| Current Accrued Expenses | $1,088,751 | $570,259 | $585,279 | $271,262 |
| Dueto Related Parties Current | $2,957,472 | $1,226,885 | $236,882 | $1,947,154 |
| Net PPE | $2,944,087 | $3,256,489 | $2,971,078 | $2,339,923 |
| Accumulated Depreciation | $-1,605,012 | $-1,330,697 | $-956,549 | $-460,923 |
| Gross PPE | $4,549,099 | $4,587,186 | $3,927,627 | $2,800,846 |
| Leases | $1,129,681 | $1,125,581 | $1,139,087 | $256,548 |
| Machinery Furniture Equipment | $1,968,656 | $1,846,895 | $1,751,163 | $465,845 |
| Buildings And Improvements | $1,450,762 | $1,576,814 | $999,285 | $2,049,775 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-89,349 | $-79,464 | $-73,821 | $0 |
| Other Inventories | $293,159 | $324,588 | $412,129 | $122,966 |
| Raw Materials | $300,180 | $195,974 | $145,108 | $104,287 |
| Duefrom Related Parties Current | $53,784 | $12,400 | $83,102 | $19,055 |
| Goodwill | - | $0 | $0 | $0 |
| Other Properties | - | $37,896 | $38,092 | $28,678 |
| Finished Goods | - | $0 | $521 | $6,201 |
| Work In Process | - | $0 | $15,315 | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-1,873,274 | $-1,691,778 | $-1,781,288 | $-59,145 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-1,628,834 | $-1,392,259 | $-1,624,565 | $-57,804 |
| Cash Flow From Continuing Operating Activities | $-1,628,834 | $-1,392,259 | $-1,624,565 | $-57,804 |
| Operating Gains Losses | $63,105 | $362 | - | - |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-244,440 | $-299,519 | $-156,723 | $-1,341 |
| Investing Cash Flow | $-195,235 | $-302,838 | $-3,522,369 | $-4,431,513 |
| Cash Flow From Continuing Investing Activities | $-195,235 | $-302,838 | $-3,522,369 | $-4,431,513 |
| Net Other Investing Changes | $24,867 | - | - | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Financing Cash Flow | $1,426,442 | $1,560,466 | $-2,389,593 | $5,221,864 |
| Cash Flow From Continuing Financing Activities | $1,426,442 | $1,560,466 | $-2,389,593 | $5,221,864 |
| Net Other Financing Charges | $1,426,442 | $1,560,466 | $-2,389,593 | $5,590,512 |
| Issuance Of Capital Stock | - | - | - | $4,386,070 |
| Net Common Stock Issuance | - | - | - | $4,386,070 |
| Common Stock Issuance | - | - | - | $4,386,070 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $4,367 | $71,163 | $404,276 |
| End Cash Position | $62,310 | $466,966 | $619,900 | $8,600,853 |
| Beginning Cash Position | $466,966 | $619,900 | $8,600,853 | $7,676,689 |
| Effect Of Exchange Rate Changes | $-7,029 | $-18,303 | $-444,426 | $191,617 |
| Changes In Cash | $-397,627 | $-134,631 | $-7,536,527 | $732,547 |
| Net Business Purchase And Sale | $0 | $-3,319 | $-3,365,646 | $-4,430,172 |
| Purchase Of Business | $0 | $-3,319 | $-3,812,027 | $-4,517,620 |
| Net Intangibles Purchase And Sale | $-2,779 | $-4,032 | $0 | - |
| Purchase Of Intangibles | $-2,779 | $-4,032 | $0 | - |
| Net PPE Purchase And Sale | $-217,323 | $-295,487 | $-156,723 | $-1,341 |
| Sale Of PPE | $24,338 | $0 | - | - |
| Purchase Of PPE | $-241,661 | $-295,487 | $-156,723 | $-1,341 |
| Change In Working Capital | $350,208 | $272,960 | $134,535 | $-177,743 |
| Change In Other Working Capital | $-40,971 | $37,275 | $-24,401 | $-122,897 |
| Change In Payables And Accrued Expense | $454,270 | $-279,564 | $221,612 | $-226,835 |
| Change In Accrued Expense | $28,304 | $-161,393 | $289,868 | $-142,027 |
| Change In Payable | $425,966 | $-118,171 | $-68,256 | $-84,808 |
| Change In Account Payable | $403,236 | $-66,161 | $69,455 | $-27,341 |
| Change In Tax Payable | $22,730 | $-52,010 | $-137,711 | $-57,467 |
| Change In Income Tax Payable | $22,730 | $-52,010 | $-137,711 | $-57,467 |
| Change In Prepaid Assets | $192,022 | $133,513 | $103,016 | $1,372 |
| Change In Inventory | $-88,249 | $36,240 | $150,872 | $69,738 |
| Change In Receivables | $-166,864 | $345,496 | $-316,564 | $100,879 |
| Changes In Account Receivables | $-205,593 | $477,951 | $-426,003 | $5,887 |
| Other Non Cash Items | $113,971 | $-332,277 | $126,560 | $-61,901 |
| Stock Based Compensation | $301,127 | $371,540 | $371,540 | $371,540 |
| Provisionand Write Offof Assets | $-10,186 | $-39,992 | $100,852 | $0 |
| Deferred Tax | $0 | $15,152 | $1,858 | $-18,570 |
| Deferred Income Tax | $0 | $15,152 | $1,858 | $-18,570 |
| Depreciation Amortization Depletion | $321,282 | $410,690 | $185,565 | $96,106 |
| Depreciation And Amortization | $321,282 | $410,690 | $185,565 | $96,106 |
| Amortization Cash Flow | $6,143 | $1,339 | $2,023 | - |
| Amortization Of Intangibles | $6,143 | $1,339 | $2,023 | - |
| Depreciation | $315,139 | $409,351 | $183,542 | - |
| Gain Loss On Sale Of PPE | $63,105 | $362 | $0 | - |
| Net Income From Continuing Operations | $-2,768,341 | $-2,090,694 | $-6,369,245 | $-267,236 |
| Sale Of Business | - | $0 | $446,381 | $87,448 |
| Asset Impairment Charge | - | $0 | $3,823,770 | $0 |
| Repayment Of Debt | - | - | $0 | $-368,648 |
| Net Issuance Payments Of Debt | - | - | $0 | $-368,648 |
| Net Long Term Debt Issuance | - | - | $0 | $-368,648 |
| Long Term Debt Payments | - | - | $0 | $-368,648 |